Fosun Pharma will invest $9.7 million into Biosino Bio-Technology and Science in a move to increase its presence in the in-vitro diagnostic sector. After the transaction is completed, Fosun will hold approximately 24% of Biosino’s outstanding shares. The shares were priced at HK$2.36 (US$.30), about a 20% discount to Biosino’s recent trading price. More details...